Your session is about to expire
← Back to Search
Noninvasive Brain Stimulation
TMS and tDCS for Motor Skill Learning
N/A
Waitlist Available
Led By Heidi Schambra-Griesemer, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 days
Awards & highlights
Study Summary
This trial will use TMS and tDCS to study how the brain learns new motor skills, in order to understand the neurophysiological changes that occur during this process.
Who is the study for?
This trial is for right-handed individuals who can consent to participate. It's not suitable for those with a seizure history, drug/alcohol abuse, unstable social situations, head injury or surgery, psychoactive medication use, metal in the head (except dental), implanted thoracic devices, or active neurological/psychiatric conditions.Check my eligibility
What is being tested?
The study investigates how the brain learns new motor skills using noninvasive stimulation techniques like tDCS-NeuroConn and TMS-Magstim. Participants will undergo these stimulations to see changes in movement kinematics and cortical circuitry during skill acquisition.See study design
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site, mild headache or dizziness post-treatment with tDCS or TMS. There's also a low risk of inducing seizures with TMS in susceptible individuals.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Motor skill gain from day 1 to day 5
Trial Design
3Treatment groups
Active Control
Placebo Group
Group I: Transcranial magnetic stimulation (TMS)Active Control1 Intervention
TMS is delivered noninvasively via a hand-held coil applied to the surface of the head, and a magnetic pulse probes cortical circuitry [this is not repetitive TMS and so does NOT modulate brain excitability.]
Group II: Transcranial direct current stimulator (tDCS)Active Control1 Intervention
tDCS is delivered noninvasively via electrodes applied to the surface of the head, and a mild electrical current is given during motor training.
Group III: Sham-tDCSPlacebo Group1 Intervention
delivered by briefly turning on and off the stimulator at the beginning of training, which mimics the sensation of true stimulation.
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,731 Total Patients Enrolled
Heidi Schambra-Griesemer, MDPrincipal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have the ability to give informed consent.\nYou have medical devices implanted in your chest, like pacemakers, pumps, or lines.You primarily use your right hand for writing and other activities.You have metal in your head that is not in your mouth, like surgical clips or fragments from metalwork.You do not have a stable place to live or other social circumstances that would make it difficult to attend all required study visits.You currently have a drug or alcohol addiction or a history of drug or alcohol abuse.I have had seizures in the past.I understand and can participate in all required procedures.I have ongoing neurological, psychiatric, or other medical conditions.I have had a head injury or neurosurgery in the past.You are currently taking medication for a mental health condition.
Research Study Groups:
This trial has the following groups:- Group 1: Transcranial magnetic stimulation (TMS)
- Group 2: Transcranial direct current stimulator (tDCS)
- Group 3: Sham-tDCS
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Transcranial Direct Current Stimulation Patient Testimony for trial: Trial Name: NCT03190590 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this research endeavor still in progress?
"According to the clinicaltrials.gov database, this trial is no longer seeking participants. Initially posted on March 20th 2018 and most recently edited in August 22nd 2022, it has ceased recruitment; however, 18 other trials are still accepting patients at this time."
Answered by AI
Who else is applying?
What state do they live in?
Connecticut
Kentucky
What site did they apply to?
New York University School of Medicine
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I want to improve my memory.
PatientReceived 2+ prior treatments
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger